Senseonics Initiates First-in-Human Study of Freedom CGM System
Senseonics has initiated a first-in-human study of its Freedom continuous glucose monitoring system, designed to have no on-body component.
Senseonics has initiated a first-in-human study of its Freedom continuous glucose monitoring system, designed to have no on-body component.